Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...

A groundbreaking approach led by a team of scientists, including Rice University chemist James Tour, has the potential to ...

In pancreatic cancer, symptoms are unclear and often emerge late in its progression. It is difficult to treat once the cancer has spread, as it cannot be removed completely with surgery. Now ...

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic cancer.

Understanding the mechanisms of resistance to cancer treatments is necessary to find effective therapies at different stages of the disease. Scientists at UT Southwestern Medical Center studied the ...

Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.

008). The main chemotherapy regimens for first-line treatment were 5-fluorouracil, oxaliplatin, folinic acid and irinotecan and gemcitabine plus capecitabine. No significant survival difference was ...

The aging population and lifestyle-related factors contribute to a surge in pancreatic cancer cases. The aggressive nature of the disease and its high mortality rate demand innovative therapies.